[go: up one dir, main page]

PE97199A1 - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number
PE97199A1
PE97199A1 PE1998000573A PE00057398A PE97199A1 PE 97199 A1 PE97199 A1 PE 97199A1 PE 1998000573 A PE1998000573 A PE 1998000573A PE 00057398 A PE00057398 A PE 00057398A PE 97199 A1 PE97199 A1 PE 97199A1
Authority
PE
Peru
Prior art keywords
esters
sterby
soltrilized
sertralina
compositions
Prior art date
Application number
PE1998000573A
Other languages
English (en)
Spanish (es)
Inventor
Ravi Mysore Shanker
Scott Max Herbig
Dwayne Thomas Friesen
James Blair West
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE97199(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE97199A1 publication Critical patent/PE97199A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE1998000573A 1997-07-01 1998-06-26 Composiciones solubilizadas de sertralina PE97199A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
PE97199A1 true PE97199A1 (es) 1999-10-05

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000573A PE97199A1 (es) 1997-07-01 1998-06-26 Composiciones solubilizadas de sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (pt)
JP (1) JP2000514100A (pt)
KR (1) KR100366373B1 (pt)
CN (1) CN1261794A (pt)
AP (1) AP1192A (pt)
AR (3) AR015917A1 (pt)
AU (1) AU742535B2 (pt)
BG (1) BG103918A (pt)
BR (1) BR9810739A (pt)
CA (1) CA2290974C (pt)
CO (1) CO4940495A1 (pt)
DZ (1) DZ2548A1 (pt)
EA (1) EA002481B1 (pt)
HN (1) HN1998000102A (pt)
HR (1) HRP980377A2 (pt)
HU (1) HUP0002236A3 (pt)
ID (1) ID23429A (pt)
IL (1) IL133076A (pt)
IS (1) IS5260A (pt)
MA (1) MA24587A1 (pt)
NO (1) NO996520L (pt)
OA (1) OA11243A (pt)
PA (1) PA8454301A1 (pt)
PE (1) PE97199A1 (pt)
PL (1) PL337804A1 (pt)
SK (1) SK181099A3 (pt)
TN (1) TNSN98124A1 (pt)
TR (1) TR199903297T2 (pt)
TW (1) TW550087B (pt)
UA (1) UA67741C2 (pt)
UY (1) UY25071A1 (pt)
WO (1) WO1999001120A1 (pt)
YU (1) YU68299A (pt)
ZA (1) ZA985708B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
WO2002017918A2 (en) 2000-08-30 2002-03-07 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) * 2022-05-20 2022-08-12 中化地质矿山总局地质研究院 一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
MA24587A1 (fr) 1998-12-31
UY25071A1 (es) 2000-12-29
OA11243A (en) 2003-07-24
UA67741C2 (uk) 2004-07-15
AR015917A1 (es) 2001-05-30
EP0999829A1 (en) 2000-05-17
WO1999001120A1 (en) 1999-01-14
IL133076A (en) 2003-12-10
HUP0002236A3 (en) 2003-12-29
EA199900962A1 (ru) 2000-08-28
CA2290974A1 (en) 1999-01-14
AU742535B2 (en) 2002-01-03
PA8454301A1 (es) 2000-09-29
BG103918A (en) 2000-07-31
TR199903297T2 (xx) 2000-07-21
PL337804A1 (en) 2000-09-11
DZ2548A1 (fr) 2003-02-08
AR040280A2 (es) 2005-03-23
JP2000514100A (ja) 2000-10-24
YU68299A (sh) 2002-06-19
ZA985708B (en) 2000-01-10
IS5260A (is) 1999-11-19
CO4940495A1 (es) 2000-07-24
BR9810739A (pt) 2000-09-12
KR20010013365A (ko) 2001-02-26
HUP0002236A2 (hu) 2003-08-28
AR040279A2 (es) 2005-03-23
CA2290974C (en) 2004-04-27
AP9801280A0 (en) 1998-06-30
TW550087B (en) 2003-09-01
SK181099A3 (en) 2000-07-11
NO996520L (no) 2000-02-29
HN1998000102A (es) 1999-01-08
IL133076A0 (en) 2001-03-19
TNSN98124A1 (fr) 2005-03-15
NO996520D0 (no) 1999-12-28
EA002481B1 (ru) 2002-06-27
AP1192A (en) 2003-07-23
KR100366373B1 (ko) 2003-01-14
ID23429A (id) 2000-04-20
HRP980377A2 (en) 1999-04-30
AU7544898A (en) 1999-01-25
CN1261794A (zh) 2000-08-02

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2151464T3 (es) Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
AR012531A1 (es) Composicion para cuidado personal, composicion para repasador y metodo para minimizar o reducir la comezon o quemado de la piel a causa de composicionespara cuidado personal que contienen acido.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
CO5640073A2 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
ATE438304T1 (de) Eine säure und/oder alkohol enthaltendes wasserstoffperoxid-desinfektionsmittel
ES2195798T1 (es) Formulacion para mujeres menopausicas.
PE20000522A1 (es) Activos donantes protonicos en articulos absorbentes
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
AR015884A1 (es) Una composicion cosmetica para su uso en aplicaciones para el cuidado personal, que comprende un portador y una biguanida polimerica, uso de la misma y uso de una biguanida polimerica.
BR9914799A (pt) Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido
PE97199A1 (es) Composiciones solubilizadas de sertralina
AR018357A1 (es) Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
AR056268A1 (es) Tabletas que comprenden una sustancia biologicamente activa y un excipiente
PT697814E (pt) Formulacoes para verter que contem material polimerico glicois e gliceridos
AR003893A1 (es) Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol.
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
BR9814756A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
MY143793A (en) Non-tabletted, chewable, individually dosed administration forms
ES2190819T3 (es) Procedimiento de preparacion de formulaciones galenicas noveles que contienen fenobrinato, formulaciones galenicas asi obtenidas y sus aplicaciones.
ES2143481T3 (es) Comprimido de valproato de sodio de liberacion lenta.
AR024313A1 (es) Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed